Avery Bio Corporation

San Diego, CA

UEI
FRN3WHBZKNA5
CAGE
984T8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1869 Caminito Ascua, La Jolla, CA 92037, USA
Website
averybio.com
Founded
2020
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Similar vendors

About the company

Avery Bio Corporation is a corporate entity registered in SAM.gov, located in La Jolla, California, that is classified as a self-certified small disadvantaged business and a for-profit organization. The company appears to specialize in advanced biotechnology research and development, with a particular focus on innovative DNA synthesis and assembly technologies. While specific details about the company's full range of services are not provided in the available information, the federal grant awards suggest a deep expertise in cutting-edge genetic engineering and electronic nanochannel chip technologies for DNA manipulation.

The company has been awarded multiple significant federal grants from the National Institute of General Medical Sciences, focusing on revolutionary DNA assembly techniques. These grants, totaling approximately $2-3 million, support research into electronically controlled DNA synthesis and assembly on semiconductor chips. Specific research projects include developing long DNA assembly on electronic nanochannel chip devices, creating electronically addressable DNA assembly methods, and designing an integrated circuit electrical DNA assembly system. The research aims to dramatically reduce the cost and complexity of gene synthesis, with potential applications in synthetic biology, bioengineering, and advanced medical research. The projects seek to enable massive parallelization of gene synthesis, potentially reducing costs by up to 100x and increasing the ability to generate complex genetic constructs, which could have transformative implications for genetic engineering, drug development, and personalized medicine.

Quick answers

Is Avery Bio Corporation registered in SAM.gov?

Yes. Avery Bio Corporation's SAM.gov registration is active through July 21, 2027.

What is Avery Bio Corporation's CAGE code?

Avery Bio Corporation's CAGE code is 984T8, and its Unique Entity ID (UEI) is FRN3WHBZKNA5.

What is Avery Bio Corporation's most recent federal award?

Avery Bio Corporation's most recent federal grant award is Long DNA assembly on electronic nanochannel chip devices - the long-term objective of this research program is to… (R43GM154597), from National Institute of General Medical Sciences (NIH), on May 1, 2024.

On GovTribe

See Avery Bio Corporation's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe